Glioma
Conditions
Interventions
Gold Standard:Surgical or pathological biopsy
follow-up results of imaging examinations
Index test:Imaging was performed on patients with brain tumors who had been injected with 18F-FET using PET/CT and PET/MR.
Sponsors
The First Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1. Adult patients (aged 18-85 years); 2. Patients with suspected or newly diagnosed or previously treated glioma (MRI, CT, tumor marker test report or pathology report); 3. Patients who can provide written informed consent (signed by participants, parents or legal representatives) 4. Can keep lying flat and still for more than 15 minutes; (5) patients with concurrent 18F-FDG and 18F-FETPET/CT or PET/MR Scans;
Exclusion criteria
Exclusion criteria: 1. Pregnant patients; 2. Patients with ethanol allergy; 3. Claustrophobic patients; 4. Unable to stay flat and still for more than 15 minutes for various reasons; 5. Study participants, parents, or legal representatives were unable or unwilling to provide written informed consent; 6. The investigator considered that the patient was not suitable for the study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Standard uptake value;Standard uptake value max;Standard uptake value mean;Standard uptake value Minimum;Metabolic tumor volume;Total lesion glycolysis; | — |
Countries
China
Contacts
Public ContactZeyu Wang
The First Affiliated Hospital of Harbin Medical University
Outcome results
None listed